10 defensive stocks that can also provide you with growth and dividends over the long termMarket Watch • 08/10/22
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15Business Wire • 08/08/22
Pfizer Inks $5.4 Billion Deal To Acquire Global Blood TherapeuticsInvestors Business Daily • 08/08/22
Vaccine Targeting Fast-Spreading Omicron Subvariants Could Be Ready For Fall As Pfizer, BioNTech Announce TrialsForbes • 08/08/22
Pfizer confirms to acquire Global Blood Therapeutics for $5.4 billion in deal that gives it access to sickle-cell disease treatmentMarket Watch • 08/08/22
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare HematologyBusiness Wire • 08/08/22
Pfizer agrees to buy Global Blood Therapeutics in deal valued at $5.4 billion: WSJMarket Watch • 08/08/22